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ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2004.07.061Objective: Cardiopulmonary bypass elicits systemic inflammation. Depletion of
circulating leukocytes might alleviate inflammatory response. We studied the effects
of a leukocyte-depleting filter on phagocyte activation during cardiopulmonary
bypass.
Methods: Fifty patients undergoing coronary artery bypass grafting were randomly
allocated into an arterial line leukocyte filter group (n 25) with a Pall LeukoGuard
6 leukocyte-depleting filter (LG6; Pall Biomedical, Portsmouth, United Kingdom)
and a control group without any filter (n  25). Blood sampling took place from
arterial line at predetermined time points. In the filter group, the sample was taken
immediately before the filter; to evaluate activation at the site, an additional sample
was taken immediately after the filter. CD11b/CD18 and L-selectin expressions and
basal production of hydrogen peroxide were determined with whole-blood flow
cytometry, and plasma lactoferrin level was determined with enzyme-linked immu-
nosorbent assay.
Results: Neutrophil CD11b expression was higher in the filter group than in the
control group (P  .001). Likewise, monocyte CD11b expression, neutrophil
hydrogen peroxide production, and lactoferrin plasma levels were all significantly
higher, whereas neutrophil and monocyte counts and neutrophil L-selectin expres-
sion were all significantly lower in the filter group (all P  .001). At 5 minutes of
CPB, CD11b expression increased across the filter on neutrophils (median differ-
ence 197 relative fluorescence units, range 45-431 relative fluorescence units, P 
.001) and monocytes (median difference 26 relative fluorescence units, range
68-111 relative fluorescence units, P  .001).
Conclusion: The LG6 arterial line leukocyte filter is ineffective in its principal task
of diminishing phagocyte activation during cardiopulmonary bypass.
Cardiopulmonary bypass (CPB) is associated with the development ofsystemic inflammation1 characterized by the systemic release of proin-flammatory cytokines and activation of the endothelium and phago-cytes (neutrophils and monocytes).2 During CPB, complement-derivedC5a mediates the early phase of systemic inflammation.3 Concomi-tantly, aortic crossclamping results in myocardial ischemia, followed
by endothelial activation during reperfusion.1 The activated endothelium promotes
phagocyte adherence, manifested as rolling and firm adhesion, mediated by selectins and
2-integrins, followed by emigration of phagocytes in postcapillary venules.2 Phagocyte
activation itself is designated by increases in cell surface integrin CD11b/CD18 expres-
sion and concomitant decreases in L-selectin cell surface density.2
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reactive oxygen species, causing microvascular damage and
organ dysfunction.4 In experimental CPB, postbypass myo-
cardial and pulmonary functions improve consistently when
a leukocyte-depleting arterial line filter is used to reduce the
number of circulating neutrophils.5-9 According to in vitro
studies, such filters eliminate mainly neutrophils,10 particu-
larly activated ones.11 In clinical studies, however, the re-
sults have been ambiguous. Although some improvements
in the variables studied have been reported,12-17 Mihaljevic
and colleagues18 found that the use of a leukocyte filter was
in fact associated with poor postoperative oxygenation and
high plasma levels of elastase, an activation marker of
neutrophils. Scholz and associates19 have reported increased
neutrophilic degranulation when using leukocyte filters.
To date, the effect of the leukocyte-depleting filter on the
development of systemic inflammation during clinical CPB
has not been explored systematically. We hypothesized that
the leukocyte filter, by increasing the amount of unphysio-
logic surface of the extracorporeal circuit, would aggravate
phagocyte activation. To address this question, we studied
markers of systemic inflammation (phagocyte CD11b and
L-selectin expressions, intracellular hydrogen peroxide pro-
duction, and plasma lactoferrin level) during CPB with and
without a leukocyte-depleting arterial line filter. Further-
more, paired blood samples across the filter were taken to
evaluate phagocyte activation within the filter.
Materials and Methods
Patients
The study was approved by the institutional ethics committee.
Before surgery, informed consent was obtained from each patient.
Patients with significant valvular dysfunction or any renal, liver or
pancreatic disease were excluded. Patients undergoing elective
coronary artery bypass grafting were randomly allocated into two
groups: the filter group (n  25) with a Pall LeukoGuard 6
leukocyte-depleting filter (LG6; Pall Biomedical, Portsmouth,
United Kingdom) used during CPB and the control group (n 25)
with no arterial line filter.
Anesthesia and CPB
Routine medications were terminated the evening before the op-
eration, except for -blockers and long-acting nitrates. Aspirin was
halted 1 week before surgery. Total anesthesia with intravenous
propofol, alfentanil, and rocuronium was standardized. Outside the
range of propofol and alfentanil infusion rates, hemodynamic
control was provided by bolus doses of nitroglycerin, ephedrin, or
norepinephrine. All patients received 20 mg/kg tranexamic acid
(Caprilon; Leiras Inc, Turku, Finland) before CPB. Aprotinin and
steroids were not used.
In all patients, a membrane oxygenator (CombactFlo; Dideco
SpA, Mirandola, Italy) was used. In the filter group, we used a
leukocyte-depleting arterial line filter (LG6) that combines both a
40-m polyester screen and leukocyte-depleting filtration media.
In the control group, no arterial line filter was used. The extracor-
852 The Journal of Thoracic and Cardiovascular Surgery ● Apriporeal circuit was primed with 2000 mL Ringer acetate solution.
Before cannulation, patients received 300 IU/kg heparin (Heparin
Leo; Leo Pharma AB, Malmö, Sweden). The activated clotting
time was kept above 480 seconds with additional heparin boluses.
All surgical procedures were performed with moderate hypother-
mia (nasopharyngeal temperature 33°C-34°C). Cold crystalloid
cardioplegic solution was used. During CPB, pump flow was kept
at 2.4 L/(min · m2), and perfusion pressure was kept between 50
and 80 mm Hg. Hemofiltration was not used. Before separation
from CPB, all patients were rewarmed (nasopharyngeal tempera-
ture 37°C and bladder temperature 36°C). After venous decan-
nulation, 1.2 mg protamine sulfate (Protamin-sulfat; Leo-Pharma
AS, Oslo, Norway) per 100 units of heparin used was given as an
infusion. Suction blood and the volume remaining in the CPB
circuit were reinfused.
Blood Sampling
In all patients, blood samples were taken at the following time
TABLE 1. Patient characteristics and clinical outcomes
Control group
Leukocyte filter
group
Patients (No.) 25 25
Male 18 20
Female 7 5
Age (y, median and range) 64 (50-78) 66 (51-73)
Patients with previous acute MI
(No.)
11 11
Number of affected coronary
arteries
Two-vessel disease (No.) 5 2
Three-vessel disease (No.) 20 23
LVEF before surgery (median
and range)
60% (40-83%) 55% (40-83%)
Duration of CPB (min, median
and range)
90 (62-130) 83 (51-154)
Duration of aortic
crossclamping (min, median
and range)
62 (34-99) 58 (28-112)
Pao2/FIO2 ratio before extubation
(mm Hg, median and range)
261 (150-568) 294 (153-426)
Time to extubation (min, median
and range)
524 (302-865) 475 (345-757)
Postop CK-MB (U/L, median and
range)
30 (5-265) 24 (5-190)
Postop weight gain (kg, median
and range)
3.2 (0.7-7.3) 3.5 (1.5-10.4)
ICU stay (d, median and range) 1 (1-5) 1 (1-5)
Hospital stay (d, median and
range)
7 (5-17) 7 (6-13)
Postop stroke (No.) 0 1
Postop mortality (%) 0 0
MI, Myocardial infarction; LVEF, left ventricular ejection fraction; PaO2,
arterial oxygen tension; FIO2, inspired oxygen fraction, CK, creatine kinase;
ICU, intensive care unit.points: after the induction of anesthesia but before surgery, imme-
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immediately before aortic declamping, 5 minutes after aortic
declamping, and 5 minutes after cessation of CPB but before
protamine administration. In all patients, arterial blood samples
were drawn from radial arterial cannula before and after CPB.
During CPB, blood samples were drawn from arterial line of the
extracorporeal circuit. In the filter group, corresponding samples
were drawn simultaneously before and after the filter mounted in
the arterial line. The volume of each blood sample was 5 mL. For
analysis of leukocyte adhesion molecules, 3 mL of each blood
sample was transferred into a tube (Falcon No. 2058; Becton
Figure 1. Neutrophil (PMN, A) and monocyte (B) count
percentiles and central lines indicate median, with w
immediately before CPB; 5’ CPB, 5 minutes of CPB; 30’ C
declamping; 5’ declamp, 5 minutes after aortic declamp
monocyte counts, P < .001 between groups, P < .001 tiDickinson Labware, Lincoln Park, NJ) containing 500 L citrate
The Journal of Thoraci(Baxter Health Care, Norfolk, United Kingdom), and a 75-L
aliquot was removed for labeling with monoclonal antibodies. The
rest of citrated blood was centrifuged at 4°C for 10 minutes at
1000g, and plasma was separated and stored at 70°C for lacto-
ferrin determination. For analysis of neutrophil hydrogen peroxide
production, 1 mL of each blood sample was incubated in the dark
at 37°C for 15 minutes in a polystyrene tube supplemented with
175 L citrate and 2 L of 120-L/mL 2,7-dichlorofluorescein-
diacetate (DCFH-DA; Eastman Kodak Company, Rochester, NY).
Thereafter, the tube was stored at 0°C in an ice-water bath in the
dark until further handling. Finally, 1 mL of each blood sample
ontrol and filter groups. Boxes indicate 25th and 75th
ers representing range. 0, Before surgery; pre CPB,
30 minutes of CPB; declamp, immediately before aortic
post CPB, 5 minutes after CPB. For both neutrophil and
ffect within groups, 1-way repeated measures ANOVA.s in c
hisk
PB,
ing,was transferred into an ethylenediaminetetraacetic acid tube (Va-
c and Cardiovascular Surgery ● Volume 129, Number 4 853
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Kingdom) and stored at room temperature for analysis of leuko-
cyte differential counts (Advia 120; Bayer, Terrytown, NY).
Laboratory Assays
All steps from blood sampling to cell staining were carried out
at 0°C in an ice-water bath to minimize artifactual increases in
adhesion molecule expression caused by sample handling.20
Neutrophil and monocyte CD11b and L-selectin (CD62L) ex-
pressions and basal intracellular hydrogen peroxide production
were determined by flow cytometry as previously de-
scribed.20,21 Adhesion molecule expression and 2’-7’-dichlo-
rofluorescein (DCF) fluorescence (intracellular hydrogen per-
oxide production) are reported as relative fluorescence units
(RFU), the mean channel number of the positively fluorescing
cell population. Plasma concentration of lactoferrin was mea-
sured by enzyme-linked immunosorbent assay.22
Statistical Analysis
Because the data distribution was skewed in the filter group
according to the Kolmogorov-Smirnov test, a nonparametric ap-
proach was instituted. The Mann-Whitney U test was used to
compare the groups, and the Wilcoxon signed rank test was used
for paired comparisons across the filter (after filter minus before
filter). To evaluate time-dependent changes within the groups and
the interaction between the groups, 1-way repeated measures anal-
ysis of variance (ANOVA) was used after appropriate logarithmic
transformation of skewed variables. Data are given as medians
with ranges.
Results
Filter and control groups were comparable with respect to
preoperative patient characteristics, durations of extracor-
poreal perfusion and aortic crossclamping, and postopera-
tive recovery (Table 1).
Neutrophil and Monocyte Counts
Before surgery, neutrophil counts were comparable in the
TABLE 2. Differences across the filter (after filter minus b
5 min CPB
Cell counts (109 cells/L)
PMNs 0.01 (0.26-0.08)
Monocytes 0.01 (0.05-0.03)
CD11b expression (RFU)
PMN 197 (45-431)*
Monocytes 26 (68-111)*
L-selectin expression (RFU)
PMN 8 (26-49)†
Monocytes 4 (92-51)
PMN hydrogen peroxide production (RFU) 50 (324-440)
Plasma lactoferrin level ( g/L) 39 (117-350)
Data are expressed as medians with ranges. PMN, Neutrophil (polymorph
*P  .05, †P  .01 after filter versus before filter, Wilcoxon signed rankgroups (Figure 1, A). Compared with the preoperative level,
854 The Journal of Thoracic and Cardiovascular Surgery ● Apriat 5 minutes of CPB, the neutrophil count had decreased in
both groups, but more so in the filter group (median 0.82 
109 cells/L, range 0.24-1.75  109 cells/L) than in the
control group (median 1.67  109 cells/L, range 0.93-4.22
 109 cells/L, P  .001, Mann-Whitney U test). In both
groups, the count increased toward the end of CPB, but it
remained lower in the filter group (P  .001 between
groups, P  .001 time effect within groups, 1-way repeated
measures ANOVA, Figure 1, A). At 30 minutes of CPB, a
marginal yet statistically significant decrease in neutrophil
count occurred across the filter (Table 2).
Preoperative monocyte counts were comparable in the
groups (Figure 1, B). At 5 minutes of CPB, monocyte count
had decreased in both groups, but more so in the filter
group. Thereafter, monocyte count remained lower in the
filter group (P  .001 between the groups, P  .001 time
effect within groups, 1-way repeated measures ANOVA,
Figure 1, B). There was no difference in the monocyte count
across the filter (Table 2).
Neutrophil and Monocyte CD11b Expression
Before surgery, neutrophil CD11b expression was compa-
rable in the groups (Figure 2, A). In the control group,
neutrophil CD11b expression gradually increased during
CPB (Figure 2, A), whereas in the filter group, CD11b
expression abruptly increased during the initial minutes of
CPB and at 5 minutes of CPB was already higher (median
795 RFU, range 359-1235 RFU) than in the control group
(median 239 RFU, range 185-450 RFU, P  .001, Mann-
Whitney U test). Neutrophil CD11b expression peaked at 30
minutes but remained higher in the filter group throughout
CPB (P .001 between groups, P .001 time effect within
groups, 1-way repeated measures ANOVA; Figure 2, A). At
5 minutes of CPB, an increase in neutrophil CD11b expres-
filter) during CPB
30 min CPB At declamping
5 min after
declamping
0.01 (0.32-0.13)* 0.04 (0.43-0.24) 0.03 (1.27-0.37)
0.00 (0.04-0.31) 0.01 (0.05-0.04) 0.00 (0.05-0.09)
17 (62-157) 0 (61-64) 6 (41-66)
3 (165-215) 4 (133-70) 12 (247-111)
1 (227-32) 1 (53-26) 0 (9-14)
6 (75-33) 3 (35-138) 1 (33-241)
32 (125-1315) 14 (48-936)† 4 (84-1057)
65 (896-750) 11 (1875-1857) 170 (4359-2104)
lear leukocyte).efore

onucsion occurred across the filter (median difference 197 RFU,
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Table 2).
Preoperative monocyte CD11b expression was compara-
ble in the groups (Figure 2, B). At 5 minutes of CPB,
monocyte CD11b expression was already higher in the filter
group (median 238 RFU, range 143-407 RFU) than in the
control group (median 151 RFU, range 89-257 RFU, P 
.001, Mann-Whitney U test), and remained high thereafter
(P  .001 between groups, P  .001 time effect within
Figure 2. Neutrophil (A) and monocyte (B) CD11b express
percentiles and central lines indicate median, with whis
ately before CPB; 5’ CPB, 5 minutes of CPB; 30’ CPB, 30 mi
5’ declamp, 5 minutes after aortic declamping, post CPB,
expressions, P < .001 between groups, P < .001 time efgroups, 1-way repeated measures ANOVA; Figure 2, B) At
The Journal of Thoraci5 minutes of CPB, an increase in monocyte CD11b expres-
sion occurred across the filter (median difference 26 RFU,
range 68-111 RFU, P  .001, Wilcoxon signed rank test;
Table 2).
Neutrophil and Monocyte L-selectin Expression
Before surgery, neutrophil L-selectin expression was com-
parable in the groups (Figure 3, A). During CPB, neutrophil
L-selectin expression increased gradually in the control
in control and filter groups. Boxes indicate 25th and 75th
representing range. 0, Before surgery; pre CPB, immedi-
of CPB; declamp, immediately before aortic declamping;
utes after CPB. For both neutrophil and monocyte CD11b
ithin groups, 1-way repeated measures ANOVA.ions
kers
nutes
5 mingroup, whereas the expression in the filter group remained at
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time effect in control group, P  .067 time effect in filter
group, 1-way repeated measures ANOVA; Figure 3, A). At
5 minutes of CPB, a decrease in neutrophil L-selectin ex-
pression occurred across the filter (Table 2).
Preoperative monocyte L-selectin expression was com-
Figure 3. Neutrophil (A) and monocyte (B) L-selectin e
and 75th percentiles and central lines indicate median
CPB, immediately before CPB; 5’ CPB, 5 minutes of CPB
aortic declamping; 5’ declamp, 5 minutes after aort
neutrophil and monocyte L-selectin expressions, P <
Neutrophil L-selectin expression increased significantl
significantly with time in filter group (P  .067). Monoc
effect P < .001), but less so in filter group (time effecparable in the groups (Figure 3, B ). At 5 minutes of CPB,
856 The Journal of Thoracic and Cardiovascular Surgery ● Aprimonocyte L-selectin expression was already slightly
lower in the filter group, and it remained so during CPB
(P  .001 between groups, P  .001 time effect in
control group, P  .014 time effect in filter group, 1-way
repeated measures ANOVA; Figure 3, B ). There was no
difference in monocyte L-selectin expression across the
sions in control and filter groups. Boxes indicate 25th
h whiskers representing range. 0, Before surgery; pre
CPB, 30 minutes of CPB; declamp, immediately before
clamping, post CPB, 5 minutes after CPB. For both
between groups, 1-way repeated measures ANOVA.
control group (time effect P < .001) but did not change
-selectin expression increased in control group (time
.014).xpres
, wit
; 30’
ic de
.001
y in
yte Lfilter (Table 2).
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ETNeutrophil Respiratory Burst Activity
Before surgery, neutrophil hydrogen peroxide production,
measured as DCF fluorescence, was comparable in the
groups (Figure 4, A). CPB induced an increase in DCF
fluorescence in both groups (Figure 4, A). Like CD11b
expression, neutrophil DCF fluorescence was already higher
in the filter group (median 430 RFU, range 273-804 RFU)
than in the control group (median 173 RFU, range 80-433
RFU, P .001, Mann-Whitney U test) at 5 minutes of CPB.
Figure 4. Neutrophil hydrogen peroxide production mea
lactoferrin (B) in control and filter groups. Boxes indicate
with whiskers representing range. 0, Before surgery; pre
CPB, 30 minutes of CPB; declamp, immediately before aor
post CPB, 5 minutes after CPB. For both neutrophil hydrog
P < .001 between groups, P < .001 time effect within grThereafter, the DCF fluorescence decreased in the filter
The Journal of Thoracigroup but still remained at a higher level than in the control
group (P  .001 between groups, P  .001 time effect
within groups, 1-way repeated measures ANOVA; Figure 4,
A). At 5 minutes after aortic declamping, an increase in
hydrogen peroxide production occurred across the filter
(Table 2).
Plasma Lactoferrin Level
Before surgery, plasma lactoferrin level was comparable in
as DCF fluorescence (A) and plasma concentration of
and 75th percentiles and central lines indicate median,
, immediately before CPB; 5’ CPB, 5 minutes of CPB; 30’
clamping; 5’ declamp, 5 minutes after aortic declamping,
roxide production and plasma lactoferrin concentration,
, 1-way repeated measures ANOVA.sured
25th
CPB
tic dethe groups (Figure 4, B). CPB induced a time-dependent
c and Cardiovascular Surgery ● Volume 129, Number 4 857
Evolving Technology Ilmakunnas et al
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group, however, this increase was steeper (P  .001 be-
tween groups, P  .001 time effect within groups, 1-way
repeated measures ANOVA; Figure 4, B). There was no
difference in plasma levels of lactoferrin across the filter
(Table 2).
Discussion
A leukocyte-depleting filter, when used throughout CPB,
enhanced activation of circulating phagocytes, measured as
increased CD11b and decreased L-selectin expression, and
increased hydrogen peroxide production. Importantly,
plasma lactoferrin was higher in the filter group. Whereas
CD11b and L-selectin expression and hydrogen peroxide
production define the activation state of circulating phago-
cytes, plasma lactoferrin level indicates intravascular neu-
trophil activation in toto. The rationale for filtering arterial
line blood is to remove activated phagocytes from the
circulation, thereby decreasing systemic inflammation dur-
ing cardiac and pulmonary reperfusion. Our findings show
that, in terms of phagocyte activation, this goal was not
achieved with the leukocyte-depleting filter used.
Although plasma lactoferrin level was clearly elevated in
the filter group, it is impossible to determine whether neu-
trophil activation occurred within the filter, the microvas-
cular bed, or both. At 5 minutes after onset of CPB, neu-
trophil and monocyte CD11b expression increased and
neutrophil L-selectin expression decreased across the filter,
indicating that, at least at the beginning of CPB, the filter
itself activated neutrophils and monocytes and allowed the
activated phagocytes to pass through the filter. Later during
CPB, however, no differences were observed across the
filter. Neutrophil activation within the filter may have
ceased as a result of saturation of the filter.10,23 Alterna-
tively, activation may have continued, but gradient across
the filter was below the detection limit. Indeed, comparison
of simultaneously taken blood samples across the filter
measures changes only during a single passage of blood
through the filter and may be hampered by entrapment of a
low number of cells.
Plasma lactoferrin level increased steadily during CPB
in the filter group. Because lactoferrin’s half-life is only
45 minutes,24 increasing lactoferrin level is unlikely to
have been caused by accumulation of this granular pro-
tein in the blood stream. The finding thus reflects ongoing
neutrophil activation throughout CPB. Because filter-
induced neutrophil activation occurs possibly only at the
beginning of CPB, steadily increasing lactoferrin level
may originate from neutrophils adhering to the capillary
beds. Further, no entrapment of neutrophils was observed
in the filter during CPB. Thus lower counts of circulating
neutrophils in the filter group may reflect capillary bed
sequestration of activated neutrophils. This would also
858 The Journal of Thoracic and Cardiovascular Surgery ● Apriexplain the steadily decreasing pattern of CD11b expres-
sion and hydrogen peroxide production as activated neu-
trophils leave the circulation. Theoretically, the filter
might therefore increase adherence of circulating neutro-
phils and potentiate neutrophil-mediated adverse effects
of CPB. However, we did not observe any difference in
clinical outcome between the groups. All in all, although
not harmful, the filter seem ineffective in its task to
minimize neutrophil activation.
Chen and colleagues25 reported that neutrophils in pa-
tients undergoing CPB with a filter showed low expression
of both CD11b and L-selectin. These results are controver-
sial, however, because low CD11b expression denotes a low
activation state, whereas low L-selectin expression denotes
a high activation state of the very same neutrophil popula-
tion. In other words, neutrophils according to one index
were activated but according to another were not. Inconsis-
tent results of Chen and colleagues25 and the discrepancy
between their and our CD11b results may be due to differ-
ences in sample handling. To prevent increase in CD11b
expression ex vivo, Chen and colleagues25 treated blood
samples with formalin solution at 37°C. Such treatment,
however, interferes with subsequent leukocyte staining with
commercial antibodies,20 and we therefore preferred rapid
sample cooling at 0°C to formalin fixation.
The mechanisms of filter-induced phagocyte activation
are unknown. According to the manufacturer, the LG6 filter
is composed of a special leukocyte-depleting filtration me-
dium of unannounced composition and polyester fiber ele-
ments intended to trap leukocytes, particularly neutrophils.
Within the filter, CD11b/CD18 complex is the most prob-
able molecule to mediate neutrophil adherence to filter
elements, because it mediates phagocyte adhesion to a va-
riety of foreign bodies.26,27 Additionally, CD11b/CD18 and
L-selectin mediate cell-to-cell contacts, such as phagocyte
aggregation.28 Further, they promote phagocyte activa-
tion.29 The cell-to-cell contacts are reversible events.30 The
filter possibly promotes transient phagocyte adherence, fol-
lowed by detachment and reentry of activated cells into the
circulation. In addition, phagocytes trapped by the filter may
release inflammatory mediators, promoting phagocyte tis-
sue sequestration.1,2 Phagocyte overactivation in the filter
group coincided with cardiac and pulmonary reperfusion
after aortic declamping. At that critical moment, phagocyte
activation is not desirable, because it may enhance myocar-
dial and pulmonary reperfusion injury.
We conclude that the use of the LG6 arterial line leukocyte
filter is associated with increased neutrophil and monocyte
activation. At least at the beginning of CPB, the increased
phagocyte activation is localized in the filter itself. The results
give credence to the view that, if not harmful, the LG6 leuko-
cyte-depleting filter is at least ineffective in its principal task of
diminishing phagocyte activation during CPB.
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